Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 20, 2019
Establishing Radiolanthanum Chemistry for Targeted Nuclear Medicine ApplicationsEduardo Aluicio-Sarduy, Nikki A Thiele, Kirsten E Martin, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|December 5, 2022
Evaluation of linear versus star-like polymer anti-cancer nanomedicines in mouse modelsLibor Kostka, Lenka Kotrchová, Eva Randárová, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|August 22, 2022
Multimodal imaging demonstrates enhanced tumor exposure of PEGylated FUD peptide in breast cancerHye Jin Lee, Metti K Gari, David R Inman, et al.Frontiers in Chemistry|May 14, 2023
Cyclotron production of <sup>43</sup>Sc and <sup>44g</sup>Sc from enriched <sup>42</sup>CaO, <sup>43</sup>CaO, and <sup>44</sup>CaO targetsKaelyn V Becker, Eduardo Aluicio-Sarduy, Tyler Bradshaw, et al.Inorganic Chemistry|October 4, 2021
A Third Generation Potentially Bifunctional Trithiol Chelate, Its <sup>nat,1XX</sup>Sb(III) Complex, and Selective Chelation of Radioantimony (<sup>119</sup>Sb) from Its Sn TargetAeli P Olson, Li Ma, Yutian Feng, et al.Nuclear Medicine and Biology|June 30, 2023
Production and radiochemistry of antimony-120m: Efforts toward Auger electron therapy with <sup>119</sup>SbThomas I Kostelnik, Aeli P Olson, Aivija Grundmane, et al.Nuclear Medicine and Biology|October 3, 2019
Improved production of <sup>76</sup>Br, <sup>77</sup>Br and <sup>80m</sup>Br via CoSe cyclotron targets and vertical dry distillationPaul A Ellison, Aeli P Olson, Todd E Barnhart, et al.Angewandte Chemie (International Ed. in English)|January 29, 2025
Towards the Stable Chelation of Radioantimony(V) for Targeted Auger TheranosticsAeli P Olson, Briana R Schrage, Md Faizul Islam, et al.Biorxiv : the Preprint Server for Biology|July 29, 2024
Effects of clinically relevant radionuclides on the activation of a type I interferon response by radiopharmaceuticals in syngeneic murine tumor modelsCaroline P Kerr, Julia Sheehan-Klenk, Joseph J Grudzinski, et al.Cancer Immunology Research|May 29, 2025
The Effects of Clinically Relevant Radionuclides on the Activation of an IFN1 Response Correlate with Radionuclide Half-life and Linear Energy Transfer and Influence Radiopharmaceutical Antitumor EfficacyCaroline P Kerr, Julia Sheehan-Klenk, Joseph J Grudzinski, et al.Pageof 2